UK: New type 2 diabetes treatment option

Type 2 diabetes drug empagliflozin Draft guidance recommends empagliflozin for treating type 2 diabetes after preliminary appraisal last August. NICE called for more evidence to demonstrate that empagliflozin was a good use of NHS resources compared with other already available treatments. Boehringer Ingelheim submitted a new cost effectiveness model showing that empagliflozin combination therapy is…

Read More